These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11480400)

  • 41. Pharmaceuticals and related drugs.
    Gilpin RK; Gilpin CS
    Anal Chem; 2007 Jun; 79(12):4275-93. PubMed ID: 17511425
    [No Abstract]   [Full Text] [Related]  

  • 42. European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary--Formulating better medicines for children.
    Salunke S; Hempenstall J; Kendall R; Roger B; Mroz C; Nunn T; Tuleu C
    Int J Pharm; 2011 Oct; 419(1-2):235-9. PubMed ID: 21784141
    [No Abstract]   [Full Text] [Related]  

  • 43. The Global Bioequivalence Harmonization Initiative: Summary report for EUFEPS international conference.
    Chen ML; Blume H; Beuerle G; Davit B; Mehta M; Potthast H; Schug B; Tsang YC; Wedemeyer RS; Weitschies W; Welink J
    Eur J Pharm Sci; 2018 Jan; 111():153-157. PubMed ID: 28964950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Highlights from the International Transporter Consortium second workshop.
    Zamek-Gliszczynski MJ; Hoffmaster KA; Tweedie DJ; Giacomini KM; Hillgren KM
    Clin Pharmacol Ther; 2012 Nov; 92(5):553-6. PubMed ID: 23085880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolite identification and profiling in drug design: current practice and future directions.
    Zhang Z; Zhu M; Tang W
    Curr Pharm Des; 2009; 15(19):2220-35. PubMed ID: 19601824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combinatorial chemistry in drug research from a new vantage point.
    Maehr H
    Bioorg Med Chem; 1997 Mar; 5(3):473-91. PubMed ID: 9113325
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibition constants, inhibitor concentrations and the prediction of inhibitory drug drug interactions: pitfalls, progress and promise.
    Bachmann KA
    Curr Drug Metab; 2006 Jan; 7(1):1-14. PubMed ID: 16454689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Drug transporter studies in drug discovery and development].
    Mizuno N; Niwa T
    Nihon Yakurigaku Zasshi; 2005 Apr; 125(4):200-6. PubMed ID: 15930796
    [No Abstract]   [Full Text] [Related]  

  • 49. A global view of drug-therapy interactions.
    Nacher JC; Schwartz JM
    BMC Pharmacol; 2008 Mar; 8():5. PubMed ID: 18318892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [An advancement in drug research: rational drug design with combinatorial chemistry].
    Pindur U
    Pharm Unserer Zeit; 1997 Jan; 26(1):24-30. PubMed ID: 9157462
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of New Chemical Entities as Substrates of Liver Transporters in the Pharmaceutical Industry: Response to Regulatory Requirements and Future Steps.
    Okudaira N
    J Pharm Sci; 2017 Sep; 106(9):2251-2256. PubMed ID: 28533120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ADMET--Fifth Annual SMi Conference.
    Comer JE
    IDrugs; 2010 Sep; 13(9):610-4. PubMed ID: 20799141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of statistical 'design of experiments' methods in drug discovery.
    Tye H
    Drug Discov Today; 2004 Jun; 9(11):485-91. PubMed ID: 15149624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis and use of binary encoded synthetic chemical libraries.
    Baldwin JJ
    Mol Divers; 1996 Oct; 2(1-2):81-8. PubMed ID: 9238637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How far should we go? Perspective of drug-drug interaction studies in drug development.
    Kusuhara H
    Drug Metab Pharmacokinet; 2014; 29(3):227-8. PubMed ID: 24965785
    [No Abstract]   [Full Text] [Related]  

  • 56. Regulatory aspects of drug dissolution from a European perspective.
    Graffner C
    Eur J Pharm Sci; 2006 Nov; 29(3-4):288-93. PubMed ID: 16950606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What do drug transporters really do?
    Nigam SK
    Nat Rev Drug Discov; 2015 Jan; 14(1):29-44. PubMed ID: 25475361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The rational selection of drug interaction studies: implications of recent advances in drug metabolism.
    Tucker GT
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):550-3. PubMed ID: 1490831
    [No Abstract]   [Full Text] [Related]  

  • 59. Combinatorial chemistry hits the drug market.
    Service RF
    Science; 1996 May; 272(5266):1266-8. PubMed ID: 8650537
    [No Abstract]   [Full Text] [Related]  

  • 60. Making Transporter Models for Drug-Drug Interaction Prediction Mobile.
    Ekins S; Clark AM; Wright SH
    Drug Metab Dispos; 2015 Oct; 43(10):1642-5. PubMed ID: 26199424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.